Corza Medical buys Takeda's TachoSil manufacturing operations
jetcityimage/iStock Editorial via Getty Images
Corza Medical enters agreement with a subsidiary of Takeda Pharmaceuticals to acquire the TachoSil manufacturing operations in Linz, Austria.
Corza Medical had previously acquired the commercial product rights for TachoSil in January 2021.
Closing expected in Q1 2024.
“In the last two years, we’ve significantly expanded the number of surgeons using TachoSil worldwide. With this acquisition of the TachoSil production facility in Linz, we’ve now assembled a critical piece of our growing Biosurgery business to tightly integrate customer demand with production fulfillment to provide an exceptional service experience,” said Gregory T. Lucier, Corza Medical Executive Chairman.